СТОРОЖЕВЫЕ ЛИМФАТИЧЕСКИЕ УЗЛЫ ПРИ РАКЕ ТЕЛА МАТКИ
https://doi.org/10.17650/1994-4098-2017-13-2-68-74
Аннотация
Рак тела матки традиционно лечится хирургически. Для выбора адъювантной терапии у пациенток с раком тела матки высокого риска рекомендуется полное хирургическое стадирование, включающее в себя лимфаденэктомию. Определение сторожевого лимфатического узла позволяет получить информацию о состоянии лимфатических узлов без потенциальных рисков, связанных с выполнением расширенной лимфодиссекции.
Об авторах
А. И. Беришвили
ФГБУ «Российский онкологический центр им. Н.Н. Блохина» Минздрава России
Россия
Россия
Александр Ильич Беришвили.
115478 Москва, Каширское шоссе, 23
О. В. Ли
ФГБОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова»
Россия
Россия
119991 Москва, ул. Трубецкая, 8, стр. 2
Т. М. Кочоян
ФГБУ «Российский онкологический центр им. Н.Н. Блохина» Минздрава России
Россия
Россия
115478 Москва, Каширское шоссе, 23
Н. В. Левкина
ФГБОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова»
Россия
Россия
119991 Москва, ул. Трубецкая, 8, стр. 2
Р. А. Керимов
ФГБУ «Российский онкологический центр им. Н.Н. Блохина» Минздрава России
Россия
Россия
115478 Москва, Каширское шоссе, 23
С. Б. Поликарпова
ФГБОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова»
Россия
Россия
119991 Москва, ул. Трубецкая, 8, стр. 2
Список литературы
1. Collarino A., Vidal-Sicart S., Perotti G. et al. The sentinel node approach in gynaecological malignancies. Clin Transl Imaging 2016;4:411–20. DOI: doi.org/10.1007/s40336-016-0187-6. PMID: 27738629.
2. Darai E., Dubernard G., Bats A.S. et al. Sentinel node biopsy for the management of early stage endometrial cancer: Long-term results of the SENTI-ENDO study. Gynecol Oncol 2015;136:54–59. DOI: 10.1016/j.ygyno.2014.09.011. PMID: 25450151.
3. Kumar S., Podratz K., Bakkum-Gamez J.N. et al. Prospective assessment of the preva-lence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol 2014;132:38–43. DOI: 10.1016/j.ygyno.2013.10.002. PMID: 24120926.
4. May K., Bryant A., Dickinson H.O. et al. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010;(1):60–4. DOI: 10.1002/14651858.CD007585. pub2. PMID: 20091639.
5. Benedetti Panici P., Basile S., Salerno M.G. et al. Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 2014;210:361–3. DOI: 10.1016/j.ajog.2013.12.025. PMID: 24361787.
6. Eriksson A.G., Ducie J.A., Ali N. et al. Multicenter study comparing two approaches to nodal assessment in patients with low-risk endometrial carcinoma: contemporary sentinel lymph node mapping versus historical selective systematic surgical staging. Gynecol Oncol 2015;137 (Suppl 1):6–7.
7. Ducie J.A., Eriksson A.G., Ali N., McGree M. et al. Multicenter study assessing the detection of stage IIIC endometrial cancer in intermediateand high-risk tumors between a contemporary sentinel node mapping versus historical comprehensive lymphadenectomy approach. Gynecol Oncol 2015;137(1):7.
8. Burke T.W., Levenback C., Tornos C. et al. Intraabdominal lymphatic mapping to direct pelvic and aortic lymphadenectomy in women with high risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996;62:169–73. DOI: 10.1006/gyno.1996.0211. PMID: 8751545.
9. van de Lande J., Torrenga B., Raijmakers P.G., et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol 2007;106:604–13. DOI: 10.1016/j.ygyno.2007.05.010 PMID: 17628644
10. Ballester M., Dubernard G., Rouzier R. et al. Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol 2008;15:1523–9. DOI: 10.1245/s10434-008-9841-1. PMID: 18322758.
11. Jewell E.L., Huang J.J., Abu-Rustum N.R. et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. Gynecol Oncol 2014;288(133):274–7. DOI: 10.1016/j.ygyno.2014.02.028. PMID: 24582865.
12. Ehrisman J., Secord A.A., Berchuck A. et al. Performance of sentinel lymph node biopsy in high-risk endometrial cancer. Gynecologic Oncology Reports 2016;17:69–71. DOI: 10.1016/j.gore.2016.04.002. PMID: 27453926.
13. Xiong L., Gazyakan E., Yang W. et al. Indocyanine green fluorescence-guided sentinel node biopsy: a meta-analysis on detection rate and diagnostic performance. Eur J Surg Oncol 2014;40:843–9. DOI: 10.1016/j.ejso.2014.02.228. PMID: 24613744.
14. Schaafsma B.E., Verbeek F.P., Elzevier H.W. et al. Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging. J Surg Oncol 2014;110:845–50. DOI: 10.1002/jso.23740. PMID: 25111761.
15. Barlin J.N., Khoury-Collado F., Kim C.H. et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol 2012;125:531–5. DOI: 10.1016/j.ygyno.2012.02.021. PMID: 22366409.
16. van de Lande J., Torrenga B., Raijmakers P.G. et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol 2007;106:604–13. DOI: 10.1016/j.ygyno.2007.05.010. PMID: 17628644.
17. Robova H., Charvat M., Strnad P. et al. Lymphatic mapping in endometrial cancer: comparison of hysteroscopic and subserosal injection and the distribution of sentinel lymph nodes. Int J Gynecol Cancer 2009;19(3):391–4. DOI: 10.1111/IGC.0b013e3181a1c0b1. PMID: 19407565.
18. Holub Z., Jabor A., Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol 2002;23:53–7. PMID: 11876394.
19. Gien L.T., Kwon J.S., Carey M.S. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J Obstet Gynaecol Can 2005;27:1107–12. PMID: 16524529.
20. Li B., Li X.G., Wu L.Y. et al. A pilot study of sentinel lymph node identification in patients with endometrial cancer. Bull Cancer 2007;94:E1–4. PMID: 17236998.
21. Altgassen C., Pagenstecher J., Hornung D. et al. A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol 2007;105:457–61. DOI: 10.1016/j.ygyno.2007.01.021. PMID: 17313975.
22. Frumovitz M., Bodurka D.C., Broaddus R.R. et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 2007;104:100–3. DOI: 10.1016/j.ygyno.2006.07.033. PMID: 16963111.
23. Cormier B., Rozenholc A.T., Gotlieb W. et al. Communities of Practice (CoP) Group of Society of Society of Gynecologic Oncology of Canada (GOC) Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization offuture research. Gynecol Oncol 2015;138(2):478–85. DOI: 10.1016/j.ygyno.2015.05.039. PMID: 26047592.
24. Pelosi E., Arena V., Baudino B. et al. Preoperative lymphatic mapping and intraoperative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 2003;24:971–5. DOI: 10.1097/01.mnm.0000090426.24184.32. PMID: 12960596.
25. Buda A., Crivellaro C., Elisei F. et al. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye. Ann Surg Oncol 2016;23:2183–91. DOI: 10.1245/s10434-015-5022-1. PMID: 26714944.
26. Abu-Rustum N.R., Khoury-Collado F., Pandit-Taskar N. et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol 2009 May;113(2):163–9. DOI: 10.1016/j.ygyno.2009.01.003. PMID: 19232699.
27. Papadia A., Imboden S., Siegenthaler F. et al. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer. Ann Surg Oncol 2016 Jul;23(7):2206–11. DOI: 10.1245/s10434-016-5090-x. PMID: 26790667.
28. Plante M., Touhami O., Trinh X.B. et al. Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature. Gynecol Oncol 2015;137:443–7. DOI: 10.1016/j.ygyno.2015.03.004. PMID: 25771495.
29. Sinno A.K., Fader A.N., Roche K.L. et al. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer. Gynecol Oncol 2014;134:281–6. DOI: 10.1016/j. ygyno. 2014.05.022. PMID: 24882555.
30. Rossi E.C., Jackson A., Ivanova A. et al. Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection. Int J Gynecol Cancer 2013;23:1704–11. DOI: 10.1097/IGC.0b013e3182a616f6. PMID: 24177256.
31. Perrone A.M., Casadio P., Formelli G. et al. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol 2008;111:62–7. DOI: 10.1016/j.ygyno.2008.05.032 PMID: 18625518
32. Ditto A., Martinelli F., Bogani G. et al. Sentinel node mapping using hysteroscopic injection of indocyanine green and laparoscopic near-infrared fluorescence imaging in endometrial cancer staging. J Minim Invasive Gynecol 2015;22:132–3. DOI: 10.1016/j.jmig.2014.08.009. PMID: 25135786.
33. Solima E., Martinelli F., Ditto A. et al. Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer. Gynecol Oncol 2012;126(3):419–23. DOI: 10.1016/j.ygyno.2012.05.025. PMID: 22659192.
34. Niikura H, Kaiho-Sakuma M, Tokunaga H. et al. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2013 Nov;131(2):299–303. DOI: 10.1016/j.ygyno.2013.08.018. PMID: 23988415.
35. Maccauro M., Lucignani G., Aliberti G. et al. Sentinel lymph node detection following the hysteroscopic peritumoral injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 2005;32:569–74. DOI: 10.1007/s00259-004-1709-4. PMID: 15625604.
36. Raspagliesi F., Ditto A., Kusamura S. et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: A feasibility study. Am J Obstet Gynecol. 2004;191:435–9. DOI: 10.1016/j.ajog.2004.03.008. PMID: 15343218.
37. Fersis N., Gruber I., Relakis K. et al. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol 2004;25:339–42. PMID: 15171314.
38. Kato K., Tate S., Nishikimi K. et al. Surgical anatomy of the common iliac veins during para-aortic and pelvic lymphadenectomy for gynecologic cancer. J Gynecol Oncol 2014;25:64–9. DOI: 10.3802/jgo.2014.25.1.64 PMID: 24459583/
39. AlHilli M.M., Mariani A. Preoperative selection of endometrial cancer patients at low risk for lymph node metastases: useful criteria for enrollment in clinical trials. J Gynecol Oncol 2014;25:267–9. DOI: 10.1016/j.ygyno.2014.03.567. PMID:24690476.
40. Mitamura T., Watari H., Todo Y. et al. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments. J Gynecol Oncol 2014;25:301–5. DOI: 10.3802/jgo.2014.25.4.301. PMID: 25142623.
41. Bogani G., Chiappa V., Lorusso D. et al. Treatment of Recurrent Endometrial Carcinoma: Progress Toward a More Personalized Approach. J Clin Oncol. 2015 Oct 20;33(30):3516. DOI: 10.1200/JCO.2015.61.4636. PMID: 26240220.
Рецензия
Для цитирования:
Беришвили А.И., Ли О.В., Кочоян Т.М., Левкина Н.В., Керимов Р.А., Поликарпова С.Б. СТОРОЖЕВЫЕ ЛИМФАТИЧЕСКИЕ УЗЛЫ ПРИ РАКЕ ТЕЛА МАТКИ. Опухоли женской репродуктивной системы. 2017;13(2):68-74. https://doi.org/10.17650/1994-4098-2017-13-2-68-74
For citation:
Berishvili A.I., Li O.V., Kochoyan T.M., Levkina N.V., Kerimov R.A., Polikarpova S.B. SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER. Tumors of female reproductive system. 2017;13(2):68-74. (In Russ.) https://doi.org/10.17650/1994-4098-2017-13-2-68-74
Просмотров: 493
Послать статью по эл. почте 